Welcome to LookChem.com Sign In|Join Free
  • or
1H-Indole-1-propanol, 4-methylbenzenesulfonate (ester) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

56276-07-4

Post Buying Request

56276-07-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56276-07-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 56276-07-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,2,7 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 56276-07:
(7*5)+(6*6)+(5*2)+(4*7)+(3*6)+(2*0)+(1*7)=134
134 % 10 = 4
So 56276-07-4 is a valid CAS Registry Number.

56276-07-4Downstream Products

56276-07-4Relevant academic research and scientific papers

Enantioselective Fujiwara-Moritani indole and pyrrole annulations catalyzed by chiral palladium(II)-NicOx complexes

Schiffner, Julia A.,Woeste, Thorsten H.,Oestreich, Martin

supporting information; experimental part, p. 174 - 182 (2010/04/02)

The catalytic asymmetric Fujiwara-Moritani ring closures of several indole-and pyrrole-based cyclization precursors are reported. These unprecedented oxidative palladium(II)-catalyzed annulations allow for the formation of a stereogenic quaternary carbon atom, and decent levels of enantiocontrol are seen in 5-exo-trig cyclizations (54% ee for an indole and 76% ee for a pyrrole) while 6-exo-trig ring closures afford essentially racemic material. Novel oxazoline ligands with a nicotine platform (NicOx) are pivotal for good catalytic turnover as conventional PyOx ligands failed to produce acceptable chemical yields. The preparation of these NicOx ligands as well as the syntheses of the cyclization precursors are described in detail.

Indolocarbazole imides and the use thereof

-

, (2008/06/13)

The present invention is concerned with the use of indolocarbazole imides of the general formula (I): STR1 for the preparation of pharmaceutical compositions for the treatment and/or prevention of cancer, virus diseases (for example HIV infections), heart and blood vessel diseases (for example high blood pressure, thromboses, heart rhythm disturbances and atheroscleroses), bronchopulmonary diseases, degenerative diseases of the central nervous system (for example Alzheimer's disease), inflammatory diseases (for example rheumatism and arthritis), diseases of the immune system (for example allergies), as well as psoriasis and for use as immune suppressives; as well as new compounds of general formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 56276-07-4